GOG-0249 Follow-Up Form Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Source Form: NCI FormBuilder:

  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00807768 Follow-Up - GOG-0249 Follow-Up Form - 2758826v1.0

No Instruction available.

  1. StudyEvent: GOG-0249 Follow-Up Form
    1. No Instruction available.
Header Module
Vital Status
Patient's vital status
Primary Cause of Death
Is the patient lost to follow-Up
Notice Of Progression
Has the patient been diagnosed with a new progression?
What was the method used to determine progression
Ca125 And Other Biomarkers
Notice Of New Primary
Has a new primary cancer or MDS been diagnosed that has not been previously reported? (myelodysplastic syndrome)
Late Adverse Event
Has the patient experienced (prior to diagnosis of recurrence or second primary) any severe (Grade >=3), long term toxicity that has not been previously reported
CTC adverse event attribution code (Adverse Event Attribution Codes 1=Unrelated, 2=Unlikely, 3=Possibly, 4=Probably, 5=Definitely)
Non-protocol Therapy
Is the patient receiving any non-protocol cancer therapy not previously reported?

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial